C4 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Provided By GlobeNewswire
Last update: Feb 27, 2025
Planning Activities Are Ongoing for Next Phase of Cemsidomide Clinical Development in Multiple Myeloma and Non-Hodgkin’s Lymphoma; Trials Expected to Initiate in Early 2026
Read more at globenewswire.com1.4
+0.15 (+12%)
Find more stocks in the Stock Screener
CCCC Latest News and Analysis
11 days ago - ChartmillWhich stocks are moving before the opening bell on Thursday?As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
